perillyl alcohol has been researched along with Glioma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, TC; Cho, HY; Fu, J; Hofman, FM; Minea, RO; Ou, M; Schönthal, AH; Stathopoulos, A; Swenson, SD; Tang, L; Thein, TZ; Wang, W | 1 |
| Chen, TC; da Fonseca, CO; Schönthal, AH | 1 |
| Carvalho, JF; Carvalho, MG; Da Fonseca, CO; Moura-Neto, R; Quirico-Santos, T; Silva, MM | 1 |
| Afshordel, S; Clasohm, J; Eckert, GP; Kern, B; Kögel, D; König, H; Priester, M; Weissenberger, J | 1 |
| Arnobio, A; Da Fonseca, CO; Futuro, D; Lins, IR; Quirico-Santos, T; Silva, JT; Simão, M | 1 |
| da Fonseca, CO; da Silveira, Fd; de Amorim, LM; de Palmer Paixão, IC; Lopes, Bde A; Quirico-Santos, T | 1 |
| Chen, TC; Cho, HY; Goldkorn, A; Hofman, FM; Jhaveri, N; Lee, DJ; Leong, MN; Louie, SG; Petasis, NA; Schönthal, AH; Torres, S; Tseng, J; Wang, W; Xu, T | 1 |
| Howard, SP; Rajesh, D; Stenzel, RA | 1 |
| Clark, SS; da Costa Carvalho, Mda G; da Fonseca, CO; Gattass, CR; Landeiro, JA; Quirico-Santos, T | 1 |
| da Fonseca, CO; Fischer, J; Futuro, D; Gattass, CR; Nagel, J; Quirico-Santos, T; Schwartsmann, G | 1 |
2 review(s) available for perillyl alcohol and Glioma
| Article | Year |
|---|---|
Intranasal Perillyl Alcohol for Glioma Therapy: Molecular Mechanisms and Clinical Development.
Topics: Administration, Intranasal; Antineoplastic Agents; Brain Neoplasms; Clinical Trials as Topic; Glioma; Humans; Monoterpenes; Signal Transduction; Treatment Outcome | 2018 |
Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcohol.
Topics: Antineoplastic Agents; Brain Neoplasms; Glioma; Humans; Molecular Biology; Monoterpenes | 2006 |
2 trial(s) available for perillyl alcohol and Glioma
| Article | Year |
|---|---|
Influence of GSTM1 and GSTT1 polymorphisms on the survival rate of patients with malignant glioma under perillyl alcohol-based therapy.
Topics: Adult; Aged; Aged, 80 and over; Brazil; Case-Control Studies; Demography; Exons; Female; Glioma; Glutathione Transferase; Humans; Male; Middle Aged; Monoterpenes; Polymorphism, Genetic; Survival Rate; Tumor Suppressor Protein p53; Young Adult | 2013 |
Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas.
Topics: Administration, Intranasal; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Blood-Brain Barrier; Brain Neoplasms; Dacarbazine; Disease Progression; Drug Administration Schedule; Enzyme Inhibitors; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Monoterpenes; Neoplasm Recurrence, Local; Oncogene Protein p21(ras); Signal Transduction; Survival Rate; Temozolomide; Transforming Growth Factor beta; Treatment Outcome | 2008 |
6 other study(ies) available for perillyl alcohol and Glioma
| Article | Year |
|---|---|
Inhibition of autophagy and induction of glioblastoma cell death by NEO214, a perillyl alcohol-rolipram conjugate.
Topics: Autophagy; Cell Death; Chloroquine; Glioblastoma; Glioma; Humans; Lysosomes; Monoterpenes; Rolipram; Sirolimus; Temozolomide; TOR Serine-Threonine Kinases | 2023 |
Lovastatin and perillyl alcohol inhibit glioma cell invasion, migration, and proliferation--impact of Ras-/Rho-prenylation.
Topics: Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholesterol; Glioma; Humans; Lovastatin; Monoterpenes; Neoplasm Invasiveness; Prenylation; rac1 GTP-Binding Protein; ras Proteins; Terpenes | 2015 |
Correlation of tumor topography and peritumoral edema of recurrent malignant gliomas with therapeutic response to intranasal administration of perillyl alcohol.
Topics: Administration, Intranasal; Adult; Aged; Antineoplastic Agents; Brain Edema; Brain Neoplasms; Disease-Free Survival; Female; Glioma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Monoterpenes; Neoplasm Recurrence, Local; Treatment Outcome | 2009 |
Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Brain Neoplasms; Brazil; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Epidermal Growth Factor; Female; Gene Frequency; Genotype; Glioma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Monoterpenes; Polymorphism, Single Nucleotide; Prospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2012 |
Perillyl alcohol for the treatment of temozolomide-resistant gliomas.
Topics: Administration, Intranasal; Animals; Brain Neoplasms; Cell Death; Cell Line, Tumor; Cell Proliferation; Cytokines; Dacarbazine; Drug Resistance, Neoplasm; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Glioma; Humans; Mice; Monoterpenes; Nelfinavir; Neoplasm Invasiveness; Neovascularization, Pathologic; Pyrazoles; Sulfonamides; Temozolomide; Xenograft Model Antitumor Assays | 2012 |
Perillyl alcohol as a radio-/chemosensitizer in malignant glioma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Bromodeoxyuridine; Cell Death; Cell Line; Cell Line, Tumor; Cisplatin; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Doxorubicin; Fas Ligand Protein; fas Receptor; G2 Phase; Genes, Dominant; Glioma; Humans; Membrane Glycoproteins; Mitosis; Monoterpenes; Protein Structure, Tertiary; Radiation-Sensitizing Agents; Rats; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Transfection; Up-Regulation | 2003 |